CD28 and infection: The research unveiled that the engineered cells expressing PD1/CD28 exhibited augmented secretion of various cytokines, including critical immune mediators, such as IFNγ and interleukin-2, further substantiating the use of the CSR to modulate immune responses against infections and malignancies [68].